GridAI Technologies (GRDX) Capital Expenditures (2015 - 2021)
GridAI Technologies' (GRDX) quarterly Capital Expenditures came in at -$1960.0 in Q4 2021, down 244.22% on a YoY basis from $1359.0 in Q4 2020, and up 20.97% quarter-over-quarter from -$2480.0 in Q3 2021.
Analysis
GridAI Technologies (GRDX) Capital Expenditures (2015 - 2021) Analysis & Trends
GridAI Technologies (GRDX) has reported Capital Expenditures for 7 consecutive years, with -$1960.0 the latest figure, recorded in Q4 2021.
- For the quarter ending Q4 2021, Capital Expenditures fell 244.22% year-over-year to -$1960.0; the trailing twelve-month figure through Dec 2021 stood at $69488.0 (up 1567.58% YoY), and the FY2021 full-year result was $69488.0, up 1567.58% from the prior year.
- Capital Expenditures rose to -$1960.0 in Q4 2021 per GRDX's latest filing, from -$2480.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $201641.0 in Q4 2018 and bottomed at -$2480.0 in Q3 2021.
- Historically, Capital Expenditures has averaged $21106.7 across 5 years, with a median of $5597.5 in 2019.
- The sharpest annual moves came in 2018 and 2020: Capital Expenditures soared 93686.51% in 2018, then tumbled 10113.33% in 2020.
- Over 5 years, Capital Expenditures stood at $215.0 in 2017, then jumped by 93686.51% to $201641.0 in 2018, then plunged by 96.6% to $6855.0 in 2019, then tumbled by 80.18% to $1359.0 in 2020, then plunged by 244.22% to -$1960.0 in 2021.
- According to Business Quant data, Capital Expenditures over the past three periods registered -$1960.0, -$2480.0, and $73928.0 for Q4 2021, Q3 2021, and Q2 2021 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 513.00 Mn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 140.00 Mn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 112.20 Mn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 240.20 Mn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | 37.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 34.68 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 40.90 Mn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | -1.87 Mn |
| 10 | GridAI Technologies | 19.07 Mn | 19.07 Mn | -36,514.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2021 | -1,960.00 |
| Sep 30, 2021 | -2,480.00 |
| Jun 30, 2021 | 73,928.00 |
| Dec 31, 2020 | 1,359.00 |
| Jun 30, 2020 | -1,532.00 |
| Mar 31, 2020 | 4,340.00 |
| Dec 31, 2019 | 6,855.00 |
| Sep 30, 2019 | 3,906.00 |
| Jun 30, 2019 | -15.00 |
| Mar 31, 2019 | 13,352.00 |
| Dec 31, 2018 | 201,641.00 |
| Sep 30, 2018 | 7,318.00 |
| Jun 30, 2018 | 11,520.00 |
| Mar 31, 2018 | 29,521.00 |
| Dec 31, 2017 | 215.00 |
| Sep 30, 2017 | 10,710.00 |
| Jun 30, 2017 | 20,658.00 |
| Mar 31, 2017 | 585.00 |
| Dec 31, 2016 | -785.00 |
| Sep 30, 2016 | 1,511.00 |